The Trump administration’s gutting of global aid is jeopardizing the future of a crucial network of laboratories responsible for measles and rubella surveillance worldwide. Known as the Global Measles and Rubella Laboratory Network (GMRLN), this network plays a vital role in testing for measles, generating genetic sequences of circulating strains, and providing critical information on the status of these resurgent viruses. With an annual budget of approximately $9 million, the GMRLN is instrumental in identifying and tracking measles outbreaks in various countries, such as Madagascar and Israel.
However, the sudden withdrawal of funding from the Centers for Disease Control and Prevention (CDC) has left the GMRLN on the verge of collapse. In response to this funding crisis, philanthropic leaders are now racing to save the network. The WHO Foundation, in collaboration with the Elma Vaccines and Immunization Foundation, is leading an effort to raise $3.6 million to support the GMRLN. This funding will be matched to a maximum of $2 million by the Elma Vaccines and Immunization Foundation.
Established in 2001, the GMRLN has been primarily funded by the CDC, despite being operated by the World Health Organization. The halt in funding has put the network’s future in jeopardy, prompting urgent fundraising efforts to keep it operational. The goal is to secure enough resources to sustain the GMRLN until a newer version of the network can be developed, focusing on surveillance for a broader range of pathogens, including dengue, yellow fever, and SARS-CoV-2.
The philanthropic sector is facing challenges in filling the gaps left by the reduction in global aid, but the relatively small scale of the GMRLN fundraising initiative provides hope for its preservation. Robyn Calder, president of Elma Philanthropies, views this effort as a strategic investment in global health, emphasizing the importance of maintaining disease surveillance networks to respond effectively to outbreaks.
Kate O’Brien, director of the WHO’s department of immunization, vaccination, and biologics, highlights the potential for expanding the GMRLN to incorporate surveillance for other infectious diseases, enhancing its impact and relevance. The loss of the GMRLN would not only impede measles and rubella surveillance but also hinder efforts to prevent and control these vaccine-preventable diseases.
As countries grapple with declining vaccination rates and the resurgence of measles outbreaks, the need for robust surveillance systems like the GMRLN has never been more critical. Without this network, countries risk losing their testing capacity and early warning systems for detecting measles and rubella outbreaks. The threat to the GMRLN comes at a time when measles cases are on the rise globally, underscoring the urgency of preserving this essential disease surveillance network.
In the face of escalating measles outbreaks and the ongoing threat of vaccine-preventable diseases, the preservation of the GMRLN is paramount. By rallying support from philanthropic organizations and stakeholders, there is hope for sustaining and enhancing this vital network to safeguard global health security.
